BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 12134624)

  • 1. [Tau story: from frontotemporal dementia to other tauopathies].
    Buée L; Hamdane M; Delobel P; Sambo AV; Bégard S; Ghestem A; Sergeant N; Delacourte A
    J Soc Biol; 2002; 196(1):103-8. PubMed ID: 12134624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tau protein isoforms, phosphorylation and role in neurodegenerative disorders.
    Buée L; Bussière T; Buée-Scherrer V; Delacourte A; Hof PR
    Brain Res Brain Res Rev; 2000 Aug; 33(1):95-130. PubMed ID: 10967355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal tau-containing filaments in neurodegenerative diseases.
    Crowther RA; Goedert M
    J Struct Biol; 2000 Jun; 130(2-3):271-9. PubMed ID: 10940231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The neuropathological spectrum of neurodegenerative tauopathies.
    Tolnay M; Probst A
    IUBMB Life; 2003 Jun; 55(6):299-305. PubMed ID: 12938731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frontotemporal dementia with tau pathology.
    Gasparini L; Terni B; Spillantini MG
    Neurodegener Dis; 2007; 4(2-3):236-53. PubMed ID: 17596718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tau protein as a differential biomarker of tauopathies.
    Sergeant N; Delacourte A; Buée L
    Biochim Biophys Acta; 2005 Jan; 1739(2-3):179-97. PubMed ID: 15615637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microtubule-associated protein tau gene: a risk factor in human neurodegenerative diseases.
    Schraen-Maschke S; Dhaenens CM; Delacourte A; Sablonnière B
    Neurobiol Dis; 2004 Apr; 15(3):449-60. PubMed ID: 15056452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of tau (MAPT) in frontotemporal dementia and related tauopathies.
    Rademakers R; Cruts M; van Broeckhoven C
    Hum Mutat; 2004 Oct; 24(4):277-95. PubMed ID: 15365985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Japanese contribution to the understanding of frontotemporal dementia and parkinsonism linked to chromosome 17(FTDP-17)].
    Tsuboi Y; Wszolek ZK; Mizuno Y; Kobayashi T; Yasuda M; Yamada T
    No To Shinkei; 2003 Feb; 55(2):107-19. PubMed ID: 12684990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neurodegenerative disease associated with a mutation of codon 279 (N279K) in exon 10 of Tau protein].
    Delisle MB; Uro-Coste E; Murrell JR; Rascol O; Ghetti B
    Bull Acad Natl Med; 2000; 184(4):799-809; discussion 809-11. PubMed ID: 10989564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single molecule profiling of tau gene expression in Alzheimer's disease.
    Conrad C; Zhu J; Conrad C; Schoenfeld D; Fang Z; Ingelsson M; Stamm S; Church G; Hyman BT
    J Neurochem; 2007 Nov; 103(3):1228-36. PubMed ID: 17727636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transgenic zebrafish model of neurodegeneration.
    Tomasiewicz HG; Flaherty DB; Soria JP; Wood JG
    J Neurosci Res; 2002 Dec; 70(6):734-45. PubMed ID: 12444595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tau gene mutations and their effects.
    Goedert M
    Mov Disord; 2005 Aug; 20 Suppl 12():S45-52. PubMed ID: 16092090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tau phosphorylation in neuronal cell function and dysfunction.
    Johnson GV; Stoothoff WH
    J Cell Sci; 2004 Nov; 117(Pt 24):5721-9. PubMed ID: 15537830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
    Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
    Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interface between tauopathies and synucleinopathies: a tale of two proteins.
    Galpern WR; Lang AE
    Ann Neurol; 2006 Mar; 59(3):449-58. PubMed ID: 16489609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Frontotemporal dementia: tau mutations, deposition, and molecular mechanisms of neuronal cell death].
    Hasegawa M
    Rinsho Shinkeigaku; 2004 Nov; 44(11):879-81. PubMed ID: 15651320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transgenic zebrafish as a novel animal model to study tauopathies and other neurodegenerative disorders in vivo.
    Paquet D; Schmid B; Haass C
    Neurodegener Dis; 2010; 7(1-3):99-102. PubMed ID: 20173336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increase in the relative expression of tau with four microtubule binding repeat regions in frontotemporal lobar degeneration and progressive supranuclear palsy brains.
    Ingelsson M; Ramasamy K; Russ C; Freeman SH; Orne J; Raju S; Matsui T; Growdon JH; Frosch MP; Ghetti B; Brown RH; Irizarry MC; Hyman BT
    Acta Neuropathol; 2007 Nov; 114(5):471-9. PubMed ID: 17721707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microtubule-associated protein tau in development, degeneration and protection of neurons.
    Wang JZ; Liu F
    Prog Neurobiol; 2008 Jun; 85(2):148-75. PubMed ID: 18448228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.